Prudential Financial Inc Novartis Ag Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Novartis Ag stock. As of the latest transaction made, Prudential Financial Inc holds 34,918 shares of NVS stock, worth $3.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,918

Previous 27,925 25.04%

Holding current value

$3.43 Million

Previous $2.97 Million 35.13%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $742,167 - $845,383	6,993 Added 25.04%	34,918 $4.02 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $945,509 - $1.1 Million	10,214 Added 57.67%	27,925 $2.97 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $719,955 - $819,707	-7,557 Reduced 29.91%	17,711 $1.71 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $242,946 - $267,354	2,633 Added 11.63%	25,268 $2.55 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $395,213 - $438,602	4,172 Added 22.6%	22,635 $2.31 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $487,765 - $553,085	5,272 Added 39.97%	18,463 $1.86 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $225,524 - $261,538	-2,818 Reduced 17.6%	13,191 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $411,671 - $504,141	5,449 Added 51.6%	16,009 $0
Q3 2022 Nov 04, 2022	BUY	$74.61 - $87.26 $84,010 - $98,254	1,126 Added 11.94%	10,560 $808,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $69,730 - $81,187	-866 Reduced 8.41%	9,434 $800,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $120,165 - $135,930	1,500 Added 17.05%	10,300 $904,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $15,621 - $17,273	-196 Reduced 2.18%	8,800 $736,000
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $40,153 - $46,713	-491 Reduced 5.18%	8,996 $751,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $32,987 - $36,436	387 Added 4.25%	9,487 $866,000
Q1 2021 May 12, 2021	BUY	$83.5 - $98.47 $118,737 - $140,024	1,422 Added 18.52%	9,100 $778,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $141,697 - $171,390	1,815 Added 30.96%	7,678 $725,000
Q3 2020 Aug 05, 2021	BUY	$82.14 - $91.0 $481,586 - $533,533	5,863 New	5,863 $510,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $531,610 - $588,952	-6,472 Closed	0 $0
Q2 2020 Aug 05, 2021	BUY	$80.93 - $91.1 $523,778 - $589,599	6,472 New	6,472 $565,000
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $264,155 - $297,350	-3,264 Closed	0 $0
Q1 2020 Aug 05, 2021	BUY	$70.67 - $99.01 $230,666 - $323,168	3,264 New	3,264 $269,000
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $181,833 - $254,752	-2,573 Closed	0 $0
Q4 2019 Aug 05, 2021	BUY	$84.35 - $95.37 $217,032 - $245,387	2,573 New	2,573 $244,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Novartis Ag Transaction History